|
Emmessar Biotech & Nutrition Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
17.08 Cr.
|
P/BV
|
2.22
|
Book Value (Rs.)
|
15.43
|
|
52 Week High/Low (Rs.)
|
64/27
|
FV/ML
|
10/1
|
P/E(X)
|
54.08
|
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.63
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.61 | 1.48 | 0.99 | 0.94 | 2.88 |
| Diluted EPS (Rs.) | 0.61 | 1.48 | 0.99 | 0.94 | 2.88 |
| Cash EPS (Rs.) | 0.82 | 1.70 | 1.20 | 1.14 | 3.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 15.43 | 14.82 | 13.34 | 12.35 | 11.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 15.43 | 14.82 | 13.34 | 12.35 | 11.41 |
| Revenue From Operations / Share (Rs.) | 1.22 | 1.11 | 2.04 | 0.73 | 13.99 |
| PBDIT / Share (Rs.) | 2.11 | 1.82 | 2.12 | 2.05 | 4.63 |
| PBIT / Share (Rs.) | 1.92 | 1.63 | 1.94 | 1.86 | 4.51 |
| PBT / Share (Rs.) | 1.92 | 1.63 | 1.94 | 1.86 | 4.51 |
| Net Profit / Share (Rs.) | 0.63 | 1.50 | 1.01 | 0.95 | 2.90 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 172.95 | 163.94 | 104.05 | 280.54 | 33.07 |
| PBIT Margin (%) | 156.97 | 146.36 | 94.86 | 255.24 | 32.25 |
| PBT Margin (%) | 156.87 | 146.36 | 94.86 | 255.24 | 32.25 |
| Net Profit Margin (%) | 51.75 | 135.01 | 49.43 | 130.25 | 20.73 |
| Return on Networth / Equity (%) | 4.10 | 10.12 | 7.55 | 7.70 | 25.43 |
| Return on Capital Employeed (%) | 10.96 | 9.86 | 12.85 | 13.53 | 35.20 |
| Return On Assets (%) | 3.42 | 8.57 | 6.34 | 6.58 | 18.57 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.06 | 0.06 | 0.13 | 0.04 | 1.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 15.67 | 13.56 | 14.14 | 14.73 | 3.85 |
| Quick Ratio (X) | 15.41 | 13.38 | 13.82 | 14.52 | 3.80 |
| Inventory Turnover Ratio (X) | 0.64 | 0.56 | 0.67 | 0.24 | 4.14 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 1760.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 527.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 8.31 | 8.78 | 7.28 | 9.16 | 4.87 |
| EV / Net Operating Revenue (X) | 13.61 | 15.81 | 7.14 | 25.09 | 0.69 |
| EV / EBITDA (X) | 7.87 | 9.64 | 6.87 | 8.94 | 2.11 |
| MarketCap / Net Operating Revenue (X) | 24.86 | 26.74 | 12.16 | 37.65 | 1.05 |
| Price / BV (X) | 1.97 | 2.01 | 1.86 | 2.23 | 1.29 |
| Price / Net Operating Revenue (X) | 24.87 | 26.75 | 12.16 | 37.67 | 1.05 |
| EarningsYield | 0.02 | 0.05 | 0.04 | 0.03 | 0.19 |
